Skip to main content
Howard Liebman, MD, Hematology, Los Angeles, CA

HowardA.LiebmanMDMA

Hematology Los Angeles, CA

Professor of Medicine and Pathology Keck School of Medicine of USC

Dr. Liebman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Liebman's full profile

Already have an account?

  • Office

    1441 Eastlake Ave
    Los Angeles, CA 90089
    Phone+1 323-865-3950
    Fax+1 323-865-0060

Education & Training

  • Tufts Medical Center
    Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1981 - 1984
  • University of Southern California/LAC+USC Medical Center
    University of Southern California/LAC+USC Medical CenterFellowship, Hematology, 1978 - 1981
  • University of Southern California/LAC+USC Medical Center
    University of Southern California/LAC+USC Medical CenterFellowship, Medical Oncology, 1977 - 1978
  • University of Southern California/Los Angeles General Medical Center (USC/LA General)
    University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 1974 - 1977
  • Keck School of Medicine of the University of Southern California
    Keck School of Medicine of the University of Southern CaliforniaClass of 1973

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1974 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • Donald I Feinstein chair in Hematology Department of Medicine, Keck School of Medicine, 2017
  • Top Doctors:LA Area Castle Connolly, 2013
  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Phase 2 Study of Efgartigimod, a Novel FcRn Antagonist, in Adult Patients with Primary Immune Thrombocytopenia
    Howard A. Liebman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

  • Smart Horizons Career Online Education Partners with InStride to Help Working Adults Earn Their H.S. Diplomas in Advance of Pursuing College Degrees
    Smart Horizons Career Online Education Partners with InStride to Help Working Adults Earn Their H.S. Diplomas in Advance of Pursuing College DegreesFebruary 18th, 2020
  • Acquiring Expertise for Improved Patient Outcomes in Immune Thrombocytopenia
    Acquiring Expertise for Improved Patient Outcomes in Immune ThrombocytopeniaMarch 21st, 2024

Grant Support

  • Role Of Metal Ions In The Function Of Human Factor IXNational Heart, Lung, And Blood Institute1991–1992
  • Role Of Metal Ions In The Function Of Human Factor IXNational Heart, Lung, And Blood Institute1989–1991
  • Role Of Metal Ions In The Function Of Human Factor IXNational Heart, Lung, And Blood Institute1988

Research History

  • Professor of Medicine and Pathology, Keck School of Medicine, University of Southern CaliforniaTranslational research in hemostatic and thrombotic disorders and autoimmune hematologic disorders including autoimmune hemolytic anemia and Immune thrombocytopenia1991 - Present